Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
- Wyden Statement at Finance Committee Hearing on the Trump Administration’s FY 2021 Budget with HHS Secretary Alex Azar
- Finance Democrats Denounce Trump Admin For Harmful Medicaid Block Grant Proposals
- Wyden Statement at Finance Committee Hearing on the Trump Administration’s FY 2021 Budget with Treasury Secretary Steven Mnuchin
- Wyden, Brown Introduce Bill to Block Latest Trump Administration Corporate Giveaway
- Wyden Requests State Department Documents on Trump-Era Ukraine Activities